Huberman LabDr. Casey Halpern on Huberman Lab: How DBS calms compulsions
Targeted nucleus accumbens stimulation interrupts compulsion loops; capsulotomy and DBS each help only about half of refractory OCD patients.
CHAPTERS
Meet Dr. Casey Halpern: functional neurosurgery and why DBS is uniquely powerful
Huberman introduces Dr. Casey Halpern and frames neurosurgeons as clinicians who can directly interact with brain circuits to treat disease. Halpern sets up how functional neurosurgery—especially deep brain stimulation (DBS)—can both relieve symptoms and reveal how emotion and behavior circuits work in humans.
What neurosurgeons do—and what makes deep brain stimulation different from other brain procedures
Halpern distinguishes the broad scope of neurosurgery (tumors, aneurysms, trauma, spine, peripheral nerves) from subspecialized functional neurosurgery. He explains DBS as implanting a thin wire with multiple contacts to deliver electricity like a targeted, adjustable “medication.”
Side effects that teach: emotion circuits revealed during stimulation mapping
Halpern describes how stimulating near a target can cause brief effects like laughter or panic—temporary phenomena that can be shut off immediately. These observations helped broaden DBS beyond movement disorders to psychiatric symptoms and comorbidities, suggesting overlap between motor and limbic circuits.
Defining OCD: spectrum vs disorder, and how clinicians decide when it’s pathological
Halpern frames OCD as existing on a spectrum—traits like obsessionality/compulsivity can be adaptive in certain professions, but become disabling when uncontrollable. He emphasizes that the surgical population is typically the most severe and treatment-refractory group, motivating circuit-level interventions.
Standard OCD treatments and why some patients remain refractory
The discussion reviews first-line OCD treatments—primarily serotonin-targeting medications and exposure-response prevention therapy. Halpern notes that despite strong options, a substantial minority do not achieve adequate relief, leading to consideration of more invasive approaches.
Surgical options for severe OCD: DBS vs capsulotomy (ablation) and the response ceiling
Halpern contrasts DBS with ablative approaches like capsulotomy, noting that small lesions (3–4 mm) can help with surprisingly few obvious deficits, but are irreversible. He also highlights a major limitation: even with surgery, response rates and degree of symptom relief are often modest, pushing the field toward more precise targeting.
OCD circuitry: hyperactive frontal cortex and basal ganglia loops linked to compulsion
Halpern outlines OCD as involving both cortical and subcortical dysfunction—particularly hyperactivity in prefrontal/orbitofrontal regions and their loops through the basal ganglia. He points to ventral striatum circuitry as central to compulsive behavior, connecting OCD patterns to addiction and eating disorders via “urge despite risk.”
Nucleus accumbens: reward, habit, and the biology of ‘craving’
The nucleus accumbens is presented as a hub within reward circuitry whose function can be “hijacked” by repeated exposure to powerful rewards (drugs, binge foods). Halpern clarifies the therapeutic goal is not to eliminate normal desire, but to disrupt pathological, risky, repetitive urges.
From tremor cells to craving cells: using intraoperative recordings to find symptom-specific signals
Halpern explains how DBS targeting in Parkinson’s uses microelectrode recordings—converting neural firing into sound to identify tremor-related activity. He describes translating that logic to psychiatry and eating behavior by seeking “craving” or “obsession” signals during awake procedures to guide precise electrode placement.
Non-invasive neuromodulation: TMS today and focused ultrasound as a next frontier
Huberman and Halpern evaluate non-invasive options, acknowledging both promise and mechanistic uncertainty. Halpern notes TMS is FDA-approved for depression and also for OCD and nicotine addiction, and argues it can help define circuits that might later justify invasive therapy or guide better targets.
MRI-guided focused ultrasound: lesioning, modulation, and the target-discovery problem
Halpern describes MRI-guided focused ultrasound as an FDA-approved, incisionless method to ablate tissue for tremor, producing dramatic benefit. Extending it to psychiatric disease is limited less by technology than by uncertainty about where to intervene; the field needs better circuit mapping to identify new, effective targets beyond classic capsulotomy zones.
Why awareness helps some—but fails in the most severe cases: provoking binges and decoding signals
Huberman proposes that improved self-awareness before cravings might prevent episodes; Halpern agrees but stresses that surgical candidates are often already highly aware and still lose control. He describes lab paradigms that provoke binge-related mood states while recording brain signals, using synchronized video and eye tracking to pinpoint neural changes immediately before eating.
AI, wearables, and scalable prediction of impulsive/compulsive episodes
The conversation turns to whether machine learning could predict high-risk states (e.g., suicidality, impulsive behavior) before conscious awareness, using signals like voice, sleep, and physiology. Halpern argues scalable solutions are essential given the population-level burden, but they must be grounded in real neural signal understanding to avoid ineffective “gadget” interventions.
Closing: the future of circuit-based therapies and inspiring the next generation
Huberman thanks Halpern and emphasizes the importance of the work at the cutting edge of brain repair and understanding. The episode ends with encouragement for future physicians/neurosurgeons and recognition of the broader mission: translating precise circuit interventions into better, more accessible therapies.
Get more out of YouTube videos.
High quality summaries for YouTube videos. Accurate transcripts to search & find moments. Powered by ChatGPT & Claude AI.
Add to Chrome